Morphic Medical Strengthens Senior Team with Appointment of Jane Wright as Chief Financial Officer
September 12, 2025
Read More »September 12, 2025
Read More »September 9, 2025
Read More »August 5, 2025
Morphic Medical, an innovative MedTech company that has pioneered minimally invassive treatment of obestiy and cardiometabolic disorders, today announced a leadership transition as part of its continued evolution and growth strategy.
Read More »Juli 9, 2025
Morphic Medical, creator of the world’s first medical device designed to target the underlying cause of obesity and type 2 diabetes, today announced CE (Conformité Européenne) Mark approval for the RESET® System designed to provide patients living with obesity and metabolic disorders such as Type 2 Diabetes (T2D) with the first incision-free.
Read More »November 28, 2024
Read More »November 28, 2024
Read More »November 28, 2024
Read More »November 28, 2024
A temporary 'gut liner' which makes you feel full more quickly can help keep weight off two years after it has been removed, a study found. The device – which unlike gastric bands does not require ......
Read More »Dezember 13, 2023
Morphic Medical today announced the addition of James Reinstein, Teresa Matterelli, and John Barr to the company’s Board of Directors
Read More »Juli 10, 2023
GI Dynamics is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®.
Read More »
